40% off all research productsUse codeSOFTLAUNCHApply & shop →
Lab / animal only Healthy Aging

Cardiogen

Also called AEDR; Ala-Glu-Asp-Arg

A four-amino-acid bioregulator peptide studied in heart-tissue cultures and animals. It has not been shown to repair the human heart or treat cardiovascular disease.

Overview

What it is

A synthetic tetrapeptide of alanine, glutamic acid, aspartic acid and arginine. It is unrelated to CardioGen-82, a radioactive imaging agent used in heart PET scans.

How it works

In heart tissue from young and old rats, it increased cell growth and lowered p53, a protein tied to programmed cell death. In mouse connective-tissue cells, it raised structural proteins such as actin, tubulin and lamins.

What the research shows

A patent describes protective effects in rat heart-injury experiments. A rat study with transplanted sarcoma reported more tumor-cell death and slower tumor growth. No human treatment trials were identified.

Studied for

  • Heart tissue cell growthrats, lab
  • Cell structure proteinsmouse cells
  • Heart injury modelspatent, animal

Safety and regulatory status

Safety and side effects

No dependable human side-effect data exist. Effects on cell growth and death need careful study, especially for anyone with cancer. Interactions with heart medications are unknown. Never change prescribed heart medication based on peptide claims.

Regulatory status

Not approved by the FDA for any use.

Mixing and dosing reference

Reference information only. Read before using this section.
Reference information only. Not instructions. These mixing and dosing figures summarize published studies and third-party protocols so you can understand the research. They are not medical advice, not a recommendation that anyone use any substance, and not a treatment plan. They do not apply to Research Products, which are for laboratory research only and must never be used in humans or animals. Never self-administer any compound. Only a licensed healthcare professional who has evaluated you can decide whether a medication is appropriate and how it should be used.

Cardiogen (20 mg Vial) Dosage Protocol

Vial
20 mg Cardiogen
Add diluent
3 mL
Concentration
6.67 mg/mL
1 unit (U-100)
66.67 mcg in 0.01 mL
Route
Subcutaneous

Community-Reported Use Calculations

Research PeriodAmount per AdministrationU-100 Units (mL)
10 days1 mg15 units (0.15 mL)
20 days1 mg15 units (0.15 mL)
10 days2 mg30 units (0.30 mL)
20 days2 mg30 units (0.30 mL)

How to mix

  1. Clean the vial stopper and diluent stopper with alcohol; allow both to dry.
  2. Draw exactly 3.0 mL of bacteriostatic water with a new sterile syringe, then inject it slowly down the inside wall of the vial.
  3. Gently swirl or roll until dissolved. Do not shake.
  4. Label the vial with compound, concentration, and reconstitution date. Refrigerate at 2–8 °C (36–46 °F) and protect from light.

Protocol source: PeptideDosages.com

Common questions

Is Cardiogen the same as CardioGen-82?

No. CardioGen-82 is a diagnostic imaging agent.

Does Cardiogen rebuild heart muscle?

That has not been shown in people.

Is it interchangeable with other bioregulators?

No. Different sequences have separate evidence.

Related in Healthy Aging

Sources and further reading (5)
  1. Khavinson VK, et al. AEDR stimulates cytoskeletal and nuclear matrix proteins. Bull Exp Biol Med, 2012.
  2. Chalisova NI, et al. Cardiogen and myocardial tissue culture from young and old rats. Adv Gerontol, 2009.
  3. Levdik NV, Knyazkin IV. Tumor-modifying effect of cardiogen on M-1 sarcoma in rats. Bull Exp Biol Med, 2009.
  4. NHLBI. Heart failure treatment.
  5. Source summary: PeptideDosages.com research overview (rewritten for NVO).
Educational information only. This content summarizes published research for general education. It is not medical advice, not a recommendation to use any substance, and not an instruction for human or animal use. It does not describe any Research Product sold on this site.